Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24687826

Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 May 10
First author
Escudier B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 May 10;32(14):1392-3. doi: 10.1200/JCO.2014.55.1911.
    note
    Source null
    related pmid
    24687838
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2014 May;11(5):246. doi: 10.1038/nrurol.2014.87.
    note
    Source null
    related pmid
    24731995
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2014 Nov 20;32(33):3782-3. doi: 10.1200/JCO.2014.56.8832.
    note
    Source null
    related pmid
    25267749
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2014 Nov 20;32(33):3783-4. doi: 10.1200/JCO.2014.57.9219.
    note
    Source null
    related pmid
    25267750
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2014 Nov 20;32(33):3785. doi: 10.1200/JCO.2014.57.9227.
    note
    Source null
    related pmid
    25267752
    relationship
    Comment in
  6. citation
    J Clin Oncol. 2014 Nov 20;32(33):3783. doi: 10.1200/JCO.2014.57.4673.
    note
    Source null
    related pmid
    25267763
    relationship
    Comment in
  7. citation
    Urol Oncol. 2016 May;34(5):251. doi: 10.1016/j.urolonc.2015.03.015.
    note
    Source null
    related pmid
    25937427
    relationship
    Comment in

Authors and identifiers

  1. name
    Escudier B
    type
    Author
  2. name
    Porta C
    type
    Author
  3. name
    Bono P
    type
    Author
  4. name
    Powles T
    type
    Author
  5. name
    Eisen T
    type
    Author
  6. name
    Sternberg CN
    type
    Author
  7. name
    Gschwend JE
    type
    Author
  8. name
    De Giorgi U
    type
    Author
  9. name
    Parikh O
    type
    Author
  10. name
    Hawkins R
    type
    Author
  11. name
    Sevin E
    type
    Author
  12. name
    Négrier S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Escudier B
    type
    Author
  2. name
    Porta C
    type
    Author
  3. name
    Bono P
    type
    Author
  4. name
    Powles T
    type
    Author
  5. name
    Eisen T
    type
    Author
  6. name
    Sternberg CN
    type
    Author
  7. name
    Gschwend JE
    type
    Author
  8. name
    De Giorgi U
    type
    Author
  9. name
    Parikh O
    type
    Author
  10. name
    Hawkins R
    type
    Author
  11. name
    Sevin E
    type
    Author
  12. name
    Négrier S
    type
    Author
bibliography ids
  1. nci-bib-971d76b5940a47b05beeacdc
book metadata
content sha256
6b4f031840398db59820e7788139b3292d4a5f5e8d4f67f710faa6b2ebe49f3c
document type
citation
dois
  1. 10.1200/JCO.2013.50.8267
electronic publication date
display
2014 Mar 31
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24687826
immutable id
pubmed:24687826@6b4f031840398db59820e7788139b3292d4a5f5e8d4f67f710faa6b2ebe49f3c
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
14
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1412-8
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 May 10;32(14):1392-3. doi: 10.1200/JCO.2014.55.1911.
    note
    Source null
    related pmid
    24687838
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2014 May;11(5):246. doi: 10.1038/nrurol.2014.87.
    note
    Source null
    related pmid
    24731995
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2014 Nov 20;32(33):3782-3. doi: 10.1200/JCO.2014.56.8832.
    note
    Source null
    related pmid
    25267749
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2014 Nov 20;32(33):3783-4. doi: 10.1200/JCO.2014.57.9219.
    note
    Source null
    related pmid
    25267750
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2014 Nov 20;32(33):3785. doi: 10.1200/JCO.2014.57.9227.
    note
    Source null
    related pmid
    25267752
    relationship
    Comment in
  6. citation
    J Clin Oncol. 2014 Nov 20;32(33):3783. doi: 10.1200/JCO.2014.57.4673.
    note
    Source null
    related pmid
    25267763
    relationship
    Comment in
  7. citation
    Urol Oncol. 2016 May;34(5):251. doi: 10.1016/j.urolonc.2015.03.015.
    note
    Source null
    related pmid
    25937427
    relationship
    Comment in
outcomes validated
false
pmid
24687826
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
d5ce5552e85bd1882dfc54ad2bc20e05e9360df2891c4d3cd51441a314143fff
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 May 10
precision
day
year
2014
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24687826/
title
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.

Preserved source evidence · Not medical advice